BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1791266)

  • 1. Prediction of efficacy of antidepressant by 1-week test therapy in depression.
    Nagayama H; Nagano K; Ikezaki A; Tashiro T
    J Affect Disord; 1991 Dec; 23(4):213-6. PubMed ID: 1791266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute antidepressant effect following pulse loading with intravenous and oral clomipramine.
    Pollock BG; Perel JM; Nathan RS; Kupfer DJ
    Arch Gen Psychiatry; 1989 Jan; 46(1):29-35. PubMed ID: 2642691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clomipramine versus phenelzine in obsessive-compulsive disorder. A controlled clinical trial.
    Vallejo J; Olivares J; Marcos T; Bulbena A; Menchón JM
    Br J Psychiatry; 1992 Nov; 161():665-70. PubMed ID: 1422616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression.
    Hellerstein DJ; Stewart JW; McGrath PJ; Deliyannides DA; Batchelder ST; Black SR; Withers A; O'Shea D; Chen Y
    J Clin Psychiatry; 2012 Jul; 73(7):984-91. PubMed ID: 22901348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbamazepine addition in tricyclic antidepressant-resistant unipolar depression.
    De la Fuente JM; Mendlewicz J
    Biol Psychiatry; 1992 Aug; 32(4):369-74. PubMed ID: 1420651
    [No Abstract]   [Full Text] [Related]  

  • 6. Life events and the dexamethasone suppression test in affective illness.
    Mendlewicz J; Charon F; Linkowski P
    J Affect Disord; 1986; 10(3):203-6. PubMed ID: 2943773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construct validity of the Beck Depression Inventory in a depressive population.
    Schotte CK; Maes M; Cluydts R; De Doncker D; Cosyns P
    J Affect Disord; 1997 Nov; 46(2):115-25. PubMed ID: 9479615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term efficacy and safety of milnacipran compared to clomipramine in patients with major depression.
    Leinonen E; Lepola U; Koponen H; Mehtonen OP; Rimon R
    Acta Psychiatr Scand; 1997 Dec; 96(6):497-504. PubMed ID: 9421348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of DST and TRH test administration on depression assessments: a controlled study.
    Lafer B; Fava M; Hammerness P; Rosenbaum JF
    Biol Psychiatry; 1993 Nov; 34(9):650-3. PubMed ID: 8292694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An open study of lamotrigine in refractory bipolar depression.
    Kusumakar V; Yatham LN
    Psychiatry Res; 1997 Sep; 72(2):145-8. PubMed ID: 9335206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of depression with clonazepam.
    Kishimoto A; Kamata K; Sugihara T; Ishiguro S; Hazama H; Mizukawa R; Kunimoto N
    Acta Psychiatr Scand; 1988 Jan; 77(1):81-6. PubMed ID: 3279721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationships of the Tridimensional Personality Questionnaire to mood and personality measures for depressed patients.
    Mulder RT; Joyce PR
    Psychol Rep; 1994 Dec; 75(3 Pt 1):1315-25. PubMed ID: 7892398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is the dexamethasone suppression test predictive of response to specific antidepressant treatment in major depression?
    Steardo L; Barone P; Monteleone P; Iovino M; Cardone G
    Acta Psychiatr Scand; 1987 Aug; 76(2):129-33. PubMed ID: 2890265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group.
    Calabrese JR; Bowden CL; Sachs GS; Ascher JA; Monaghan E; Rudd GD
    J Clin Psychiatry; 1999 Feb; 60(2):79-88. PubMed ID: 10084633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dexamethasone suppression test as a predictor of antidepressant response.
    Amsterdam JD; Winokur A; Bryant S; Larkin J; Rickels K
    Psychopharmacology (Berl); 1983; 80(1):43-5. PubMed ID: 6408669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of plasma levels of clomipramine, its hydroxylated and desmethylated metabolites: prediction of clinical outcome in mood disorders using discriminant analysis of therapeutic drug monitoring data.
    Noguchi T; Shimoda K; Takahashi S
    J Affect Disord; 1993 Dec; 29(4):267-79. PubMed ID: 8126313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spontaneous afternoon plasma cortisol in depression.
    Christensen P; Gram LF; Kragh-Søensen P; Christensen L; Kristensen CB; Pedersen OL; Thomsen HY
    J Affect Disord; 1985; 8(3):271-8. PubMed ID: 3160738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting outcome of lithium added to antidepressants in resistant depression.
    Alvarez E; Pérez-Solá V; Pérez-Blanco J; Queraltó JM; Torrubia R; Noguera R
    J Affect Disord; 1997 Feb; 42(2-3):179-86. PubMed ID: 9105959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Plasma levels of clomipramine and declomipramine in patients with depression: a study of its correlation with therapeutic efficacy].
    Wargny E; Lamiable D; Havet JM; Denis J; Millart H; Choisy H; Pascalis G
    Ann Med Psychol (Paris); 1986 Apr; 144(4):396-406. PubMed ID: 3813333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The DST as a predictor of acute response to treatment with ECT, chlorimipramine, amitriptyline, and phenelzine.
    Modai I; Rinsky H; Cygielman G
    J Clin Psychiatry; 1986 Mar; 47(3):139-40. PubMed ID: 3949722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.